InsiderTrades.com logo
625,000% Gain
From Crypto Swap Profits   |   Ad
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
>> Dive into the Workshop Here
Matthias Bodenstedt net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Matthias Bodenstedt Biography and Net Worth

CFO of MoonLake Immunotherapeutics
Matthias Bodenstedt, is the Chief Financial Officer of MoonLake since July 2021, and is Director of MoonLake Immunotherapeutics Ltd. since September 2021. Prior to MoonLake, Mr. Bodenstedt was a Partner at McKinsey & Company, Inc. (Switzerland), where from September 2015 to June 2021 he advised a diverse set of clients, ranging from pre-revenue biotechs to large global pharmaceutical companies, on many industry-shaping transactions on the sell- and buy-side, and worked closely with senior executives on topics such as financing, M&A, BD&L, portfolio strategy, and go-to-market strategy and execution. Mr. Bodenstedt holds an M.B.A. from Columbia Business School (New York), MPhil Finance from the University of Cambridge (United Kingdom), and B.Sc. Industrial Engineering from the University of Hannover (Germany).

What is Matthias Bodenstedt's net worth?

The estimated net worth of Matthias Bodenstedt is at least $27.24 million as of December 19th, 2023. Mr. Bodenstedt owns 526,167 shares of MoonLake Immunotherapeutics stock worth more than $27,244,927 as of November 10th. This net worth estimate does not reflect any other investments that Mr. Bodenstedt may own. Additionally, Mr. Bodenstedt receives a salary of $588,250.00 as CFO at MoonLake Immunotherapeutics. Learn More about Matthias Bodenstedt's net worth.

How old is Matthias Bodenstedt?

Mr. Bodenstedt is currently 36 years old. There are 2 older executives and no younger executives at MoonLake Immunotherapeutics. The oldest executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who is 58 years old. Learn More on Matthias Bodenstedt's age.

What is Matthias Bodenstedt's salary?

As the CFO of MoonLake Immunotherapeutics, Mr. Bodenstedt earns $588,250.00 per year. There are 2 executives that earn more than Mr. Bodenstedt. The highest earning executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who commands a salary of $1,200,000.00 per year. Learn More on Matthias Bodenstedt's salary.

How do I contact Matthias Bodenstedt?

The corporate mailing address for Mr. Bodenstedt and other MoonLake Immunotherapeutics executives is , , . MoonLake Immunotherapeutics can also be reached via phone at 41-41-510-8022 and via email at [email protected]. Learn More on Matthias Bodenstedt's contact information.

Has Matthias Bodenstedt been buying or selling shares of MoonLake Immunotherapeutics?

Matthias Bodenstedt has not been actively trading shares of MoonLake Immunotherapeutics in the last ninety days. Most recently, Matthias Bodenstedt sold 94,736 shares of the business's stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $59.22, for a transaction totalling $5,610,265.92. Following the completion of the sale, the chief financial officer now directly owns 526,167 shares of the company's stock, valued at $31,159,609.74. Learn More on Matthias Bodenstedt's trading history.

Who are MoonLake Immunotherapeutics' active insiders?

MoonLake Immunotherapeutics' insider roster includes Matthias Bodenstedt (CFO), and Simon Sturge (Director). Learn More on MoonLake Immunotherapeutics' active insiders.

Are insiders buying or selling shares of MoonLake Immunotherapeutics?

In the last twelve months, insiders at the sold shares 10 times. They sold a total of 432,717 shares worth more than $24,287,059.52. The most recent insider tranaction occured on October, 4th when Director Simon Sturge sold 171,000 shares worth more than $9,186,120.00. Insiders at MoonLake Immunotherapeutics own 12.0% of the company. Learn More about insider trades at MoonLake Immunotherapeutics.

Information on this page was last updated on 10/4/2024.

Matthias Bodenstedt Insider Trading History at MoonLake Immunotherapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2023Sell94,736$59.22$5,610,265.92526,167View SEC Filing Icon  
See Full Table

Matthias Bodenstedt Buying and Selling Activity at MoonLake Immunotherapeutics

This chart shows Matthias Bodenstedt's buying and selling at MoonLake Immunotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MoonLake Immunotherapeutics Company Overview

MoonLake Immunotherapeutics logo
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.
Read More

Today's Range

Now: $51.78
Low: $50.02
High: $52.00

50 Day Range

MA: $49.35
Low: $45.58
High: $55.40

2 Week Range

Now: $51.78
Low: $35.53
High: $64.98

Volume

195,056 shs

Average Volume

234,016 shs

Market Capitalization

$3.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28
625,000% Gain
From Crypto Swap Profits   |   Ad
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
>> Dive into the Workshop Here